Biopharma company developing targeted cancer therapies for genetically-defined patient populations
- Year invested 2014
- Investment Stage Early
- Sectors
- Investment Status Historic
- Website loxooncology.com/
- Company Status IPO/Acquired (by Eli Lilly & Co.) (NASDAQ: LOXO)